169 related articles for article (PubMed ID: 33407381)
1. Predicting Gleason sum upgrading from biopsy to radical prostatectomy pathology: a new nomogram and its internal validation.
Wang X; Zhang Y; Zhang F; Ji Z; Yang P; Tian Y
BMC Urol; 2021 Jan; 21(1):3. PubMed ID: 33407381
[TBL] [Abstract][Full Text] [Related]
2. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
[TBL] [Abstract][Full Text] [Related]
3. Gleason sum upgrading between biopsy and radical prostatectomy in Chinese population: Updated nomograms.
Xu H; Bai PD; Hu MB; Mao SH; Zhu WH; Hu JM; Liu SH; Yang T; Hou JY; Hu Y; Ding Q; Jiang HW
Actas Urol Esp; 2017 Apr; 41(3):162-171. PubMed ID: 27522521
[TBL] [Abstract][Full Text] [Related]
4. Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation.
He B; Chen R; Gao X; Ren S; Yang B; Hou J; Wang L; Yang Q; Zhou T; Zhao L; Xu C; Sun Y
Oncotarget; 2016 Mar; 7(13):17275-85. PubMed ID: 26943768
[TBL] [Abstract][Full Text] [Related]
5. PI-RADS v2 and periprostatic fat measured on multiparametric magnetic resonance imaging can predict upgrading in radical prostatectomy pathology amongst patients with biopsy Gleason score 3 + 3 prostate cancer.
Zhai L; Fan Y; Sun S; Wang H; Meng Y; Hu S; Wang X; Yu W; Jin J
Scand J Urol; 2018; 52(5-6):333-339. PubMed ID: 30895901
[TBL] [Abstract][Full Text] [Related]
6. A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients.
Wang JY; Zhu Y; Wang CF; Zhang SL; Dai B; Ye DW
Chin J Cancer; 2014 May; 33(5):241-8. PubMed ID: 24559852
[TBL] [Abstract][Full Text] [Related]
7. Analysis of risk factors for Gleason score upgrading after radical prostatectomy in a Chinese cohort.
Zhang B; Wu S; Zhang Y; Guo M; Liu R
Cancer Med; 2021 Nov; 10(21):7772-7780. PubMed ID: 34528767
[TBL] [Abstract][Full Text] [Related]
8. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
Chun FK; Steuber T; Erbersdobler A; Currlin E; Walz J; Schlomm T; Haese A; Heinzer H; McCormack M; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2006 May; 49(5):820-6. PubMed ID: 16439050
[TBL] [Abstract][Full Text] [Related]
9. External validation and comparison of two nomograms predicting the probability of Gleason sum upgrading between biopsy and radical prostatectomy pathology in two patient populations: a retrospective cohort study.
Utsumi T; Oka R; Endo T; Yano M; Kamijima S; Kamiya N; Fujimura M; Sekita N; Mikami K; Hiruta N; Suzuki H
Jpn J Clin Oncol; 2015 Nov; 45(11):1091-5. PubMed ID: 26292699
[TBL] [Abstract][Full Text] [Related]
10. External validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology among Japanese patients.
Imamoto T; Suzuki H; Utsumi T; Takano M; Suyama T; Kawamura K; Kamiya N; Naya Y; Ueda T; Ichikawa T
Urology; 2010 Aug; 76(2):404-10. PubMed ID: 19716590
[TBL] [Abstract][Full Text] [Related]
11. Comparing histology between prostate cognitive fusion targeted biopsy and radical prostatectomy: exploring risk factors of Gleason score upgrading in Chinese patients.
Zheng T; Sun H; Tang Y; Bi K; Zeng Y; Wang J; Yan L
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18029-18037. PubMed ID: 37979056
[TBL] [Abstract][Full Text] [Related]
12. Nomogram Predicting Adverse Pathology Outcome on Radical Prostatectomy in Low-Risk Prostate Cancer Men.
Nasri J; Barthe F; Parekh S; Ratnani P; Pedraza AM; Wagaskar VG; Olivier J; Villers A; Tewari A
Urology; 2022 Aug; 166():189-195. PubMed ID: 35263642
[TBL] [Abstract][Full Text] [Related]
13. Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.
Truong M; Slezak JA; Lin CP; Iremashvili V; Sado M; Razmaria AA; Leverson G; Soloway MS; Eggener SE; Abel EJ; Downs TM; Jarrard DF
Cancer; 2013 Nov; 119(22):3992-4002. PubMed ID: 24006289
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting prostatic biopsy Gleason sum under grading.
Stackhouse DA; Sun L; Schroeck FR; Jayachandran J; Caire AA; Acholo CO; Robertson CN; Albala DM; Polascik TJ; Donatucci CF; Maloney KE; Moul JW
J Urol; 2009 Jul; 182(1):118-22; discussion 123-4. PubMed ID: 19447436
[TBL] [Abstract][Full Text] [Related]
15. [Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy].
Zuo Q; Zhang F; Huang Y; Ma LL; Lu M; Lu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):603-606. PubMed ID: 29263497
[TBL] [Abstract][Full Text] [Related]
16. Can a nomogram predict apical prostate cancer pathology upgrade from fusion biopsy to final pathology? A multicenter study.
Feng T; Liang Z; Xiao Y; Pan B; Zhou Y; Ma C; Zhou Z; Yan W; Zhu M
Cancer Med; 2024 Jun; 13(11):e7341. PubMed ID: 38845479
[TBL] [Abstract][Full Text] [Related]
17. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy.
Zhou X; Ning Q; Jin K; Zhang T; Ma X
BMC Cancer; 2020 Feb; 20(1):97. PubMed ID: 32019501
[TBL] [Abstract][Full Text] [Related]
19. A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling.
Moussa AS; Kattan MW; Berglund R; Yu C; Fareed K; Jones JS
BJU Int; 2010 Feb; 105(3):352-8. PubMed ID: 19681898
[TBL] [Abstract][Full Text] [Related]
20. Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6.
Song W; Bang SH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Kim CK; Lee HM
Clin Genitourin Cancer; 2018 Aug; 16(4):281-287. PubMed ID: 29550198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
